US Broker Ratings

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Biotechnology Innovator with a Stunning 221% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is making waves in the biotechnology sector. With a market capitalization of $418.34 million, the company is..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating a 50% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (NYSE: OMI), a venerable name in the healthcare sector with roots dating back to 1882, presents a complex yet intriguing case for investors. With a current..

Septerna, Inc. (SEPN) Stock Analysis: Unpacking the 140% Potential Upside in the Biotechnology Space

Septerna, Inc. (NASDAQ: SEPN) is drawing significant attention from the investor community, given its promising potential upside of 140.03%. As a clinical-stage biotechnology company, Septerna offers a unique value proposition..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Uncovering a 41% Potential Upside in the Healthcare Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is captivating investors’ attention with a notable potential upside of over 41%, according to recent analyst ratings. As a specialty pharmaceutical company focused on innovative..

Inventiva S.A. (IVA) Stock Analysis: Unveiling a 221% Potential Upside in Biotech

Inventiva S.A. (NASDAQ: IVA) is gaining attention among investors due to its promising biopharmaceutical pipeline and a staggering potential upside of over 221%, according to the latest analyst ratings. As..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A Biopharma Player with 140% Upside Potential

For investors seeking a compelling opportunity in the healthcare sector, Akebia Therapeutics, Inc. (NASDAQ: AKBA) stands out with its remarkable potential for growth. This Cambridge, Massachusetts-based biopharmaceutical company is making..

Delcath Systems, Inc. (DCTH) Stock Analysis: Unpacking a 41% Potential Upside in the Medical Devices Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a burgeoning name in the healthcare sector, particularly in medical devices, is drawing investor attention with its impressive 41.14% potential upside. With a current market..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotechnology Innovator with 264.58% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) is making waves in the biotechnology sector with its innovative approach to the discovery and development of engineered monoclonal antibodies, targeting a range of diseases from..

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Insights into Nearly 98% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a prominent player in the biotechnology industry, focusing on nucleic acid production and biologics safety testing. With its headquarters in San Diego, California,..

Auna SA (AUNA) Stock Analysis: Strong Buy Ratings Signal Nearly 95% Upside Potential

For investors scouting the healthcare sector, Auna SA (AUNA), a Luxembourg-based healthcare service provider, presents a compelling opportunity. With operations spanning hospitals and clinics in Mexico, Peru, and Colombia, AUNA..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating the Waves of Revenue Decline and Market Potential

Investors eyeing the healthcare sector may find Semler Scientific, Inc. (NASDAQ: SMLR) an intriguing proposition, especially given its niche focus on medical devices for enhancing clinical effectiveness. Despite a challenging..

Sonida Senior Living, Inc. (SNDA): Investor Outlook with 6.47% Potential Upside

Sonida Senior Living, Inc. (SNDA), a key player in the Healthcare sector under the Medical Care Facilities industry, presents a compelling case for individual investors seeking exposure to the burgeoning..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 23.46% Potential Upside for Investors

InnovAge Holding Corp. (NASDAQ: INNV), a notable player in the healthcare sector, primarily focuses on providing comprehensive medical and ancillary services for the elderly. With its unique Program of All-Inclusive..

Amylyx Pharmaceuticals, Inc. (AMLX) Investor Outlook: Exploring a Potential 120% Upside in Biotechnology

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage biotech firm based in Cambridge, Massachusetts, offers an intriguing opportunity for investors looking to capitalize on the burgeoning healthcare sector. Specializing in the..

Geron Corporation (GERN) Stock Analysis: Exploring a 149% Potential Upside in Biotech

Geron Corporation (NASDAQ: GERN), a key player in the biotechnology sector, has been capturing investor attention with its promising outlook and significant potential upside. Currently trading at $1.48 per share,..

Oculis Holding AG (OCS) Stock Analysis: A Biotech Gem with 69.9% Potential Upside

For investors seeking promising opportunities in the biotech sector, Oculis Holding AG (OCS) is a name that stands out. The Swiss-based clinical-stage biopharmaceutical company is gaining attention for its innovative..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Bioventus Inc. (BVS) Stock Analysis: Exploring an 88% Potential Upside in the Healthcare Sector

Bioventus Inc. (NASDAQ: BVS) is making waves in the healthcare sector with an enticing potential upside of 88%, as noted by recent analyst ratings. Specializing in medical devices, this Durham,..

AMN Healthcare Services Inc (AMN) Stock Analysis: Exploring a Potential 25.82% Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find AMN Healthcare Services Inc. (NYSE: AMN) an intriguing prospect. Headquartered in Dallas, Texas, AMN provides technology-enabled healthcare workforce solutions and staffing..

Claritev Corporation (CTEV) Stock Analysis: Navigating the Complex Terrain of Healthcare Data Analytics

Claritev Corporation (CTEV), a key player in the healthcare sector specializing in health information services, is making waves with its innovative approach to data analytics and technology-enabled solutions. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds